NCT06622993

Brief Summary

Epidemiological studies show that one person in eight suffers from at least one psychiatric disorder. Mental health is therefore a major public health issue, and care for these disorders must continue to be improved. The management of mental disorders has long followed the traditional categorical approach of developing a treatment for a given disorder. However, researchers have recently pointed out the limits of this approach in the field of mental health. They highlight the large number of co-morbidities, the existence of aspecific disorders and the intra-diagnostic heterogeneity of patients. These factors have led them to develop a transdiagnostic approach, which focuses on the mechanisms common to the various disorders in order to treat them at the same time and thus reduce the cost of treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Oct 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Oct 2024Oct 2026

First Submitted

Initial submission to the registry

September 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

October 31, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

October 2, 2024

Status Verified

September 1, 2024

Enrollment Period

1.7 years

First QC Date

September 30, 2024

Last Update Submit

September 30, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evolution in Symptom Checklist Scale (SCL 90) scores between randomization and Month 3

    At the randomisation and Month 3

Secondary Outcomes (5)

  • Evolution of Transdiagnostic Skills Scale (T2S) score

    At randomisation, Month 3 and Month 6

  • Evolution of Symptomatic Transdiagnostic Test (S2T) score

    At randomisation, Month 3 and Month 6

  • Evolution of Hosptital Anxiety Depression Scalre (HADS) score

    At randomisation, Month 3 and Month 6

  • Evolution of Satisfaction with Life Scale (SWLS) score

    At randomisation, Month 3 and Month 6

  • Cumulative quantity of psychotropic treatment taken by patients (in mg)

    At randomisation, Month 3 and Month 6

Study Arms (2)

Programm SKILLS

EXPERIMENTAL
Other: Psychotherapy

Waiting list

NO INTERVENTION

Interventions

The experimental group will receive the SKILLS program, i.e. 10 group psychotherapy sessions.

Programm SKILLS

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥ 18 years of age
  • Have at least one diagnosis of a psychiatric disorder
  • Be able to carry out psychotherapy sessions
  • Have been on stable psychiatric medication for 30 days
  • Written informed consent obtained from the participant
  • Be affiliated to a social security scheme or equivalent

You may not qualify if:

  • Cognitive deficits marked by a score above the 10th percentile for one or more tests in the assessment history.
  • Persons deprived of liberty by judicial or administrative decision; Persons under legal protection: guardianship or curatorship
  • Presence of a severe depressive episode
  • Be engaged in psychotherapeutic work elsewhere
  • Presence of a state of excessive deficit, making psychotherapy impossible
  • Presence of psychic decompensation (e.g. delusions) making psychotherapy impossible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Mental Disorders

Interventions

Psychotherapy

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2024

First Posted

October 2, 2024

Study Start

October 31, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

October 2, 2024

Record last verified: 2024-09